US4349552A
(en)
|
1978-10-30 |
1982-09-14 |
Fujisawa Pharmaceutical Company, Ltd. |
5-Fluorouracil derivatives, and their pharmaceutical compositions
|
IL83821A0
(en)
|
1986-09-10 |
1988-02-29 |
Sandoz Ag |
Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them
|
WO1990007926A1
(en)
|
1989-01-20 |
1990-07-26 |
Pfizer Inc. |
3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
DE4304455A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
IL129871A
(en)
*
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
US6075037A
(en)
|
1994-06-09 |
2000-06-13 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
WO2000040581A1
(en)
|
1999-01-07 |
2000-07-13 |
American Home Products Corporation |
3,4-dihydro-2h-benzo[1,4]oxazine derivatives
|
US6313126B1
(en)
|
1999-01-07 |
2001-11-06 |
American Home Products Corp |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
CA2355342A1
(en)
|
1999-01-07 |
2000-07-13 |
American Home Products Corporation |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
US6265403B1
(en)
|
1999-01-20 |
2001-07-24 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
US20030153560A1
(en)
|
1999-04-23 |
2003-08-14 |
Salituro Francesco G. |
Inhibitors of c-Jun N-terminal kinases (JNK)
|
DE60027431T2
(de)
|
1999-07-02 |
2007-07-12 |
Stuart A. Rancho Santa Fe Lipton |
Verwendung von p38 MAPK Inhibitoren in der Behandlung von Augenkrankheiten
|
GB9919843D0
(en)
|
1999-08-20 |
1999-10-27 |
Smithkline Beecham Plc |
Novel compounds
|
DE19948417A1
(de)
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
AU2735201A
(en)
|
1999-12-28 |
2001-07-09 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
US20030004174A9
(en)
|
2000-02-17 |
2003-01-02 |
Armistead David M. |
Kinase inhibitors
|
US7041277B2
(en)
|
2000-03-10 |
2006-05-09 |
Cadbury Adams Usa Llc |
Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
WO2002014317A2
(en)
|
2000-08-14 |
2002-02-21 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted pyrazoles
|
AU2001288714A1
(en)
|
2000-09-06 |
2002-03-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
A method for treating allergies
|
DE60135130D1
(de)
|
2000-09-06 |
2008-09-11 |
Ortho Mcneil Pharm Inc |
Verwendung von substituierten pyrazolen zur behandlung von allergien
|
AR031130A1
(es)
|
2000-09-20 |
2003-09-10 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
KR20030062442A
(ko)
|
2000-12-22 |
2003-07-25 |
와이어쓰 |
5-하이드록시트립타민-6-리간드로서의 헤테로사이클인다졸및 아자인다졸 화합물
|
JP4343534B2
(ja)
|
2001-03-02 |
2009-10-14 |
ゲーペーツェー バイオテック アクチェンゲゼルシャフト |
3ハイブリッド・アッセイ・システム
|
DK1392697T3
(da)
|
2001-03-14 |
2005-02-14 |
Wyeth Corp |
Antidepressive azaheterocyclylmethylderivater af 2,3-dihydro-1,4-dioxino[2.3-f]quinolin
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
US6559169B2
(en)
|
2001-04-24 |
2003-05-06 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
US6656950B2
(en)
|
2001-04-25 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
|
US6593350B2
(en)
|
2001-04-26 |
2003-07-15 |
Wyeth |
Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
|
JP2004532236A
(ja)
|
2001-04-26 |
2004-10-21 |
ワイス |
抗うつ作用を持つ、オキサヘテロ環結合[1、4]−ベンゾジオキサンのアザヘテロシクリルメチル誘導体
|
ES2247327T3
(es)
|
2001-04-26 |
2006-03-01 |
Wyeth |
Derivados azaheterociclimetilicos antidepresivos (isrs) de 7,8-dihidro-3h-6,9-dioxa-1,3-diazaciclopenta(a) naftaleno.
|
US6656947B2
(en)
|
2001-04-26 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
|
BR0209342A
(pt)
|
2001-04-26 |
2004-06-15 |
Wyeth Corp |
Antidepressivos de azaheterociclilmetila derivados de 2,3 dihidro-1,4-dioxino[2,3-f]quinoxalina; método de tratamento usando tais compostos; processo para prepará-los
|
US6555560B2
(en)
|
2001-04-30 |
2003-04-29 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
|
BR0209407A
(pt)
|
2001-04-30 |
2004-07-06 |
Wyeth Corp |
Antidepressivos de azaheterociclilmetila derivados de 7,8-dihidro-1,6,9-trioxa-3-aza-ciclopenta[a[]naftaleno , método de tratamento usando tais compostos e processo para prepará-los
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
IL158879A0
(en)
|
2001-05-17 |
2004-05-12 |
Wyeth Corp |
PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE
|
DE60232510D1
(de)
|
2001-06-15 |
2009-07-16 |
Vertex Pharma |
5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
US6903110B2
(en)
|
2001-07-25 |
2005-06-07 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
|
MXPA04001361A
(es)
|
2001-08-14 |
2004-05-27 |
Toyama Chemical Co Ltd |
Metodo novedoso para inhibir el crecimiento de virus y/o metodo virucida, y un analogo novedoso de un nucleotido de pirazina o de un nucleosido de pirazina.
|
US20040236110A1
(en)
|
2001-09-26 |
2004-11-25 |
Ladouceur Gaetan H |
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
|
WO2003031439A1
(en)
|
2001-10-05 |
2003-04-17 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
|
US7361671B2
(en)
|
2001-11-15 |
2008-04-22 |
The Institute For Pharmaceutical Discovery, Inc. |
Substituted heteroarylalkanoic acids
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
BR0308787A
(pt)
|
2002-04-26 |
2005-01-11 |
Pfizer Prod Inc |
Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona
|
EP1506189A1
(en)
|
2002-04-26 |
2005-02-16 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
WO2003101968A1
(fr)
|
2002-05-31 |
2003-12-11 |
Eisai Co., Ltd. |
Compose de pyrazole et composition medicinale le contenant
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
DE60308387T2
(de)
|
2002-08-02 |
2007-09-20 |
Vertex Pharmaceuticals Inc., Cambridge |
Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
|
WO2004014912A1
(en)
|
2002-08-08 |
2004-02-19 |
Ribapharm Inc. |
Improved synthesis for hydroxyalkylated heterocyclic bases
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
NZ542498A
(en)
|
2003-02-26 |
2009-01-31 |
Boehringer Ingelheim Pharma |
Dihydropteridinones, method for the production and use thereof in the form of drugs
|
EP2295433A3
(en)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK inhibitors
|
US7169801B2
(en)
|
2003-03-17 |
2007-01-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
WO2005000813A1
(en)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
|
WO2004106298A1
(en)
|
2003-05-30 |
2004-12-09 |
Janssen Pharmaceutica N.V. |
Indole derivatives with an improved antipsychotic activity
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
WO2005033072A2
(en)
|
2003-09-30 |
2005-04-14 |
Scios Inc. |
Heterocyclic amides and sulfonamides
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
DK1696920T3
(en)
|
2003-12-19 |
2015-01-19 |
Plexxikon Inc |
RELATIONS AND PROCEDURES FOR THE DEVELOPMENT OF LAW MODULATORS
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
EP2311837B1
(en)
*
|
2004-03-30 |
2014-05-21 |
Vertex Pharmaceuticals Inc. |
Azaindoles useful as inhibitors of jak and other protein kinases
|
TW200604168A
(en)
|
2004-04-02 |
2006-02-01 |
Vertex Pharma |
Azaindoles useful as inhibitors of rock and other protein kinases
|
ITMI20040874A1
(it)
|
2004-04-30 |
2004-07-30 |
Ist Naz Stud Cura Dei Tumori |
Derivati indolici ed azaindolici con azione antitumorale
|
KR100476851B1
(ko)
|
2004-05-18 |
2005-03-17 |
(주)성신엔지니어링 |
중력식 섬유여과기
|
EP1755597A2
(en)
|
2004-06-17 |
2007-02-28 |
Plexxikon, Inc. |
Azaindoles modulating c-kit activity and uses therefor
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
US20050288290A1
(en)
|
2004-06-28 |
2005-12-29 |
Borzilleri Robert M |
Fused heterocyclic kinase inhibitors
|
US20060122213A1
(en)
|
2004-06-30 |
2006-06-08 |
Francoise Pierard |
Azaindoles useful as inhibitors of protein kinases
|
NZ553267A
(en)
|
2004-07-27 |
2010-09-30 |
Sgx Pharmaceuticals Inc |
Pyrrolo-pyridine kinase modulators
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CN102766142A
(zh)
|
2004-10-04 |
2012-11-07 |
千禧药品公司 |
有效作为蛋白激酶抑制剂的内酰胺化合物
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
JP5030229B2
(ja)
|
2004-11-04 |
2012-09-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なピラゾロ[1,5−a]ピリミジン
|
RU2394825C2
(ru)
|
2004-11-22 |
2010-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Пирролопиразины, пригодные в качестве ингибиторов киназы аврора а
|
EP1828180A4
(en)
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
US8101770B2
(en)
|
2004-12-16 |
2012-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyridones useful as inhibitors of kinases
|
US20060161001A1
(en)
|
2004-12-20 |
2006-07-20 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
US8633205B2
(en)
|
2005-02-03 |
2014-01-21 |
Vertex Pharmaceuticals Incorporated |
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
|
EP1896470B1
(en)
|
2005-05-16 |
2010-05-26 |
Irm Llc |
Pyrrolopyridine derivatives as protein kinase inhibitors
|
MX2007014619A
(es)
|
2005-05-20 |
2009-02-13 |
Vertex Pharma |
Pirrolopiridinas de utilidad como inhibidores de proteina quinasa.
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
AU2006297351A1
(en)
|
2005-09-30 |
2007-04-12 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of janus kinases
|
CA2628179A1
(en)
|
2005-11-15 |
2007-05-24 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
US20130096302A1
(en)
|
2005-11-22 |
2013-04-18 |
Hayley Binch |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
TW201412738A
(zh)
|
2006-01-17 |
2014-04-01 |
Vertex Pharma |
適合作為傑納斯激酶(janus kinase)抑制劑之氮雜吲哚
|
TW200804389A
(en)
|
2006-02-14 |
2008-01-16 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
AU2007215161A1
(en)
|
2006-02-14 |
2007-08-23 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases
|
DE102006012617A1
(de)
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
CN101460499A
(zh)
|
2006-04-05 |
2009-06-17 |
沃泰克斯药物股份有限公司 |
可用作janus激酶抑制剂的去氮杂嘌呤
|
BRPI0710866A2
(pt)
|
2006-04-26 |
2012-08-14 |
Hoffmann La Roche |
compostos farmacÊuticos
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
US8778977B2
(en)
|
2006-06-30 |
2014-07-15 |
Sunesis Pharmaceuticals, Inc. |
Pyridinonyl PDK1 inhibitors
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
BRPI0714908B8
(pt)
|
2006-08-08 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
derivados de pirimidina como inibidor de pi3k, composição farmacêutica e agente preventivo ou agente terapêutico de uma doença proliferativa que os compreende
|
CA2660758A1
(en)
|
2006-08-24 |
2008-02-27 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
US20130310418A1
(en)
|
2006-11-15 |
2013-11-21 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
NZ577638A
(en)
|
2006-12-14 |
2012-03-30 |
Vertex Pharma |
Tricyclic fused compounds useful as protein kinase inhibitors
|
MX2009006700A
(es)
|
2006-12-21 |
2009-06-30 |
Vertex Pharma |
Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
|
TW200840581A
(en)
|
2007-02-28 |
2008-10-16 |
Astrazeneca Ab |
Novel pyrimidine derivatives
|
CN101668760B
(zh)
|
2007-03-09 |
2013-07-24 |
沃泰克斯药物股份有限公司 |
用作蛋白激酶抑制剂的氨基嘧啶类
|
CA2679884A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
NZ579483A
(en)
|
2007-03-09 |
2012-07-27 |
Vertex Pharma |
Aminopyridines useful as inhibitors of protein kinases
|
MX2009010034A
(es)
|
2007-03-22 |
2009-10-12 |
Hoffmann La Roche |
Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
|
RU2334747C1
(ru)
|
2007-04-05 |
2008-09-27 |
Андрей Александрович Иващенко |
ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
RU2339637C1
(ru)
|
2007-04-05 |
2008-11-27 |
Андрей Александрович Иващенко |
Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
|
TW200916468A
(en)
|
2007-07-31 |
2009-04-16 |
Vertex Pharma |
Process for preparing 5-fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine and derivatives thereof
|
NZ583061A
(en)
|
2007-08-15 |
2012-06-29 |
Vertex Pharma |
4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5h-pyrimido[4,5-b[1,4]diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases
|
CN101878216B
(zh)
|
2007-09-28 |
2013-07-10 |
西克拉塞尔有限公司 |
作为蛋白激酶抑制剂的嘧啶衍生物
|
WO2009046983A1
(en)
|
2007-10-09 |
2009-04-16 |
European Molecular Biology Laboratory (Embl) |
Soluble fragments of influenza virus pb2 protein capable of binding rna-cap
|
KR20100093552A
(ko)
|
2007-11-02 |
2010-08-25 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 c-세타로서의 [1h-피라졸로[3,4-b]피리딘-4-일]-페닐 또는 -피리딘-2-일 유도체
|
PT2463282E
(pt)
|
2007-11-05 |
2013-11-11 |
Novartis Ag |
Derivados de 4-benzilamino-1-carboxiacil-piperidina como inibidores de cetp úteis para o tratamento de doenças tais como hiperlipidemia ou arteriosclerose
|
EP2247592B1
(en)
|
2008-02-25 |
2011-08-31 |
F. Hoffmann-La Roche AG |
Pyrrolopyrazine kinase inhibitors
|
WO2009145814A2
(en)
|
2008-03-10 |
2009-12-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
WO2009125395A1
(en)
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
JP5634990B2
(ja)
|
2008-06-23 |
2014-12-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
タンパク質キナーゼ阻害剤
|
EP2356122B1
(en)
|
2008-06-23 |
2019-03-20 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
JP5631310B2
(ja)
|
2008-07-23 |
2014-11-26 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
三環式ピラゾロピリジンキナーゼ阻害剤
|
CN102131807B
(zh)
|
2008-07-23 |
2013-11-20 |
沃泰克斯药物股份有限公司 |
吡唑并吡啶激酶抑制剂
|
EP2321318A1
(en)
|
2008-07-23 |
2011-05-18 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
AU2009274027A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
CA2760705A1
(en)
|
2009-05-06 |
2010-11-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
SG176722A1
(en)
*
|
2009-06-17 |
2012-01-30 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
WO2011000566A2
(en)
|
2009-06-30 |
2011-01-06 |
Savira Pharmaceuticals Gmbh |
Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
|
ES2432029T3
(es)
|
2009-07-15 |
2013-11-29 |
Abbvie Inc. |
Inhibidores de quinasas de pirrolopiridina
|
JP5685895B2
(ja)
*
|
2009-12-11 |
2015-03-18 |
株式会社リコー |
画像処理装置、画像処理方法およびプログラム
|
RS54783B1
(sr)
|
2010-04-07 |
2016-10-31 |
Vertex Pharma |
Čvrste forme 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksiamido)-3-metilpiridin-2-il)benzoeve kiseline
|
SG184870A1
(en)
|
2010-04-14 |
2012-11-29 |
Array Biopharma Inc |
5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
|
WO2011137022A1
(en)
|
2010-04-27 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Azaindoles as janus kinase inhibitors
|
AU2011343642A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
MX2013006846A
(es)
|
2010-12-16 |
2013-12-16 |
Vertex Pharma |
Inhibidores de la replicacion de los virus de la influenza.
|
AU2011343647A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2013006634A2
(en)
|
2011-07-05 |
2013-01-10 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates for producing azaindoles
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
AU2012336019A1
(en)
|
2011-11-07 |
2014-05-29 |
Vertex Pharmaceuticals Incorporated |
Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
|
WO2013184985A1
(en)
|
2012-06-08 |
2013-12-12 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2015038655A1
(en)
|
2013-09-12 |
2015-03-19 |
Alios Biopharma, Inc. |
Aza-pyridone compounds and uses thereof
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
EP3578554A1
(en)
|
2013-11-13 |
2019-12-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
MX2016006197A
(es)
|
2013-11-13 |
2016-08-08 |
Vertex Pharma |
Formulaciones de compuestos de azaindol.
|
EP3421468B1
(en)
|
2013-11-13 |
2020-11-04 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
MX2017001752A
(es)
|
2014-08-08 |
2018-02-08 |
Janssen Sciences Ireland Uc |
Indoles para su uso en la infección por el virus de la gripe.
|
US9932346B2
(en)
|
2014-09-08 |
2018-04-03 |
Janssen Sciences Ireland Uc |
Pyrrolopyrimidines for use in influenza virus infection
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
JP6857617B2
(ja)
|
2015-05-13 |
2021-04-14 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤
|
WO2016183116A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
MA43298A
(fr)
|
2015-11-27 |
2021-04-14 |
Janssen Sciences Ireland Unlimited Co |
Derives heterocycliques d'indole pour des infections par le virus de la influenza
|
MA43583A
(fr)
|
2016-01-07 |
2021-05-19 |
Janssen Sciences Ireland Unlimited Co |
Dérivés d'acide pentanoïque substitués par pyrrolo-[2,3-b]pyrimidne-pyridines pour traiter des infections par le virus de la grippe
|
LT3405466T
(lt)
|
2016-01-20 |
2021-01-25 |
Janssen Sciences Ireland Unlimited Company |
Arilu pakeistieji pirimidinai, skirti naudoti gripo viruso infekcijos atveju
|
WO2017223231A1
(en)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza
|
EP3609502A1
(en)
|
2017-04-12 |
2020-02-19 |
Vertex Pharmaceuticals Incorporated |
Combination therapies for treating influenza virus infection
|